
News|Videos|August 1, 2023
Clinical Pearls: Treating Different Patient Populations in NSCLC
Author(s)Joshua K. Sabari, MD, Narjust Florez, MD
Dr. Florez and Dr. Sabari discuss standards of care for different patient populations in NSCLC.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Early Relapse Guides Use of CAR T vs Other Options in LBCL
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5







































